PharmiWeb.com - Global Pharma News & Resources
23-Apr-2019

Fragment-based Drug Discovery Market Analysis and Growing Opportunity 2014 to 2024

Recent study titled, Fragment-based Drug Discovery Market By Analysis, Global Industry Size, Share, Trends and Forecast, 2014 - 2024which covers detailed statistical analysis and enlightens market dynamics and trends that provide a holistic picture of the industry.

TheFragment-based Drug Discovery MarketIndustry Report 2018is anin depthstudy analyzing the current state of theFragment-based Drug Discovery Market. It providesbriefoverview of the market focusing on definitions, market segmentation, end-use applicationsandindustry chain analysis. The study on Fragment-based Drug Discovery Market provides analysis of China market covering the industry trends, recent developments in the market and competitive landscape. Competitive analysis includes competitive information of leading players in China market, their company profiles, product portfolio, capacity, production, and company financials. In addition,reportalso provides upstream raw material analysis and downstream demand analysis along with the key development trends and sales channel analysis. Research study on Fragment-based Drug Discovery Market also discusses the opportunity areas for investors.

Download Sample Copy of this Report at https://www.acumenresearchandconsulting.com/request-sample/468

The report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Market Players:

The major players operating in the fragment-based drug discovery market include Alveus Pharmaceuticals Pvt. Ltd., Astex Pharmaceuticals, Charles River Laboratories International, Inc., Beactica AB, Emerald BioStructures, Inc., Crown Bioscience, Inc., Evotec AG, Proteros Fragments GmbH, Kinetic Discovery Limited, Sprint Bioscience, Sygnature Discovery and Structure Based Design, Inc. among others.

The Major Market Segments of GlobalFragment-based Drug Discovery Marketare as below:

Market Segmentation

Market By Services

middot; Fragment optimization

middot; Fragment screening

o Biophysical techniques

sect; Isothermal titration calorimetry

sect; Fluorescence polarization

sect; Nuclear magnetic resonance spectroscopy

sect; Surface plasmon resonance

sect; Differential scanning fluorimetry

sect; X-ray crystallography

sect; Mass spectrometry

sect; Biolayer interferometry

sect; Assay (thermal shift)

sect; Capillary electrophoresis

sect; Others

o Non-biophysical techniques

Market By End-Users

middot; Contract research organizations (CROs)

middot; Academic amp; research institutions

middot; Biopharmaceutical companies

Market By Geography

middot; North America

o US

o Canada

o Mexico

middot; Europe

o UK

o Germany

o France

o Rest of Europe

middot; Asia-Pacific

o China

o Japan

o India

o Australia

o Rest of Asia-Pacific

middot; Latin America

o Brazil

o Chile

o Rest of Latin America

middot; Middle East and Africa (MEA)

o South Africa

o Saudi Arabia

o Rest of MEA

Request a Table of Content, List of Table and Figures of this Research Report athttps://www.acumenresearchandconsulting.com/tentative-table-of-content/468

Would like to place an order or any question, please feel free to contact atsales@acumenresearchandconsulting.com| +1 407 915 4157

The report is readily available and can be dispatched immediately after payment confirmation.

To Purchase this Premium Report at https://www.acumenresearchandconsulting.com/buy-now/0/468

Editor Details

Last Updated: 10-Jun-2019